MCHB(MCHB)
MCHB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $796M | $837M |
| Low | $789M | $830M |
| High | $801M | $842M |
| EBITDA Avg | $274M | $288M |
| Low | $271M | $285M |
| High | $275M | $290M |
| EBIT Avg | $248M | $261M |
| Low | $246M | $259M |
| High | $250M | $263M |
| Net Income Avg | $224M | $261M |
| Low | $222M | $259M |
| High | $226M | $264M |
| EPS Avg | $1.03 | $1.20 |
| Low | $1.01 | $1.18 |
| High | $1.04 | $1.21 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $191M | $205M | $203M | $207M | $212M | $215M |
| Low | $186M | $198M | $197M | $201M | $206M | $209M |
| High | $194M | $208M | $206M | $211M | $216M | $218M |
| EBITDA Avg | $66M | $70M | $70M | $71M | $73M | $74M |
| Low | $64M | $68M | $68M | $69M | $71M | $72M |
| High | $67M | $71M | $71M | $72M | $74M | $75M |
| EBIT Avg | $60M | $64M | $63M | $65M | $66M | $67M |
| Low | $58M | $62M | $61M | $63M | $64M | $65M |
| High | $61M | $65M | $64M | $66M | $67M | $68M |
| Net Income Avg | $63M | $67M | $64M | $67M | $71M | $74M |
| Low | $60M | $64M | $62M | $65M | $68M | $71M |
| High | $64M | $68M | $66M | $69M | $73M | $76M |
| EPS Avg | $0.27 | $0.29 | $0.28 | $0.29 | $0.31 | $0.32 |
| Low | $0.26 | $0.28 | $0.27 | $0.28 | $0.29 | $0.31 |
| High | $0.28 | $0.29 | $0.28 | $0.30 | $0.31 | $0.33 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |